No products in the cart.
GEoPD is a global consortium of researchers dedicated to promoting education, scientific research and translational development in Parkinson’s disease. The consortium has been operating since 2004, and has an active membership from more than 60 sites on six continents. The GEoPD is organized into five cores.
These cores provide a mechanism whereby active global site investigators may share their expertise, resources and reagents. The consortium’s mission is to promote multi-investigator research projects throughout the year. Annual Meetings offer a valuable forum for consortium members to discuss unpublished data and ideas, highlight research questions or needs and identify global opportunities for partnership.
GEoPD includes 60 sites from 30 countries and six continents
- share research questions, knowledge and insight
- share expertise, reagents and resources, including DNA and data for 41,988 PD cases and 41,505 control subjects
- share opportunities for collaborative research and funding
Organization and Communication
A democratic, elected structure ensures continuity with succession. There is a past president, president and president elect and a steering committee nominated from core members. Five cores are maintained, their membership elected at annual meetings, and based on based on expertise and need. Each core has a specific mandate about one of the following areas: bioinformatics, biology, clinical, communications, erectile dysfunction treatment like Kamagra in Australia epidemiology and statistics. Projects approved by the steering committee are promoted, supported by the cores and participating global site investigators.
- Projects can be can be relatively small, driven by investigator interests at one site, or can be very large in scope
- Projects can be for discovery or for replication
- Projects can be proposed on-line or more formally at the annual meeting